Chlamydia trachomatis, Neisseria gonorrhoeae, Nucleic Acid Amplification Testing (NAAT)

TEST NAMEChlamydia trachomatis / Neisseria gonorrhoeae by Nucleic Acid Amplification (NAAT)
DISEASE/DISORDERChlamydia trachomatis and/or Neisseria gonorrhoeae
ALTERNATIVE NAME(S)Chlamydia, CT; GC, Gonorrhea
METHODOLOGYAptima Chlamydia trachomatis and Neisseria gonorrhoeae detection assay by nucleic acid amplification (NAAT) using the Hologic Panther System
SPECIAL INSTRUCTIONSThis assay is not approved for use in patients < 14 years of age. 
ORDERING INFORMATION

Lab Web Portal

PTBMIS:

URINE:     

Test Order Code:    GENPU   

Test Order Description:     GEN PROBE, URINE

URETHRAL SWAB:     

Test Order Code:    GENPP     

Test Order Description:     GEN PROBE, URETHRAL SWAB

ENDOCERVICAL:     

Test Order Code:    GENPE     

Test Order Description:     GEN PROBE ENDOCERVICAL

THROAT:     

Test Order Code:    GENPO     

Test Order Description:     GEN PROBE THROAT

VAGINAL:     

Test Order Code:    GENPV     

Test Order Description:     GEN PROBE VAGINAL

ANAL:     

Test Order Code:    GENPA     

Test Order Description:     GEN PROBE ANAL

Specimen Requirements


Patient Preparation
  • Refer to manufacturer instructions provided with collection kits for specific patient preparation information.
  • Only the following specimen types will be accepted for testing: Clinician-collected endocervical, vaginal, throat, rectal, and male urethral swabs, female and male urine, patient-collected vaginal swab. 
  • Specimens must be collected using the specified Aptima Specimen Collection Kit. 
Specimen Collection
  • Aptima Urine Specimen Collection Kit: female and male urine.
  • Aptima Multitest Swab Specimen Collection Kit: vaginal, throat, and rectal specimens.
  • Aptima Unisex Swab Specimen Collection Kit: endocervical and male urethral specimens.
  • Refer to appropriate specimen collection kit package insert for collection instructions.
  • Do not touch or mark upon the collection vials’ pierceable foil cap.
Specimen Processing
  • After collection, place patient sample in biohazard bag with absorbent material using care not to touch the foil cap.
Specimen Labeling
  • Specimen should be labled with at least two unique patient identifiers and specimen source and match accompanying test order.
Specimen Storage and Preservation
  • After collection, place patient sample in an individual biohazard bag with absorbent material using care not to touch the foil cap. 
  • All specimens for an individual patient may be combined in one biohazard bag.
  • Store and transport at 2 - 30°C; must arrive within 72 hours of collection. If specimens will not arrive at the laboratory within 72 hours, specimens may be stored at 4-30°C for up to 30 days. 
  • If longer storage is needed, freeze specimens in the Aptima specimen transport tube within seven (7) days of collection at -20°C to -70°C to allow testing up to twelve (12) months after collection.
Specimen Transportation
  • Specimens must be placed in an individual biohazard bag with absorbent material and should be shipped to the laboratory on the day of collection. 
  • All specimens for an individual patient may be combined in one biohazard bag.
  • Store and transport at 2 - 30°C; must arrive within 72 hours of collection. If specimens will not arrive at the laboratory within 72 hours, specimens may be stored at 4-30°C for up to 30 days. 
  • All infectious substance shipments must conform to U.S. Department of Transportation (DOT) Hazardous Materials Regulations (HMR 49 C.F.R. Parts 171-180). 
Specimen Acceptability and Rejection
  • Specimens collected from patients <14 years of age will be rejected.
  • If expiration date on tube is prior to collection date, specimen will be rejected. 
  • Specimens received in improper collection kits and/or from unapproved specimen sites will be rejected.
  • Urine specimens that are filled above or below the urine collection tube’s fill lines will be rejected.
  • Specimens received with no swab, two swabs, a cleaning swab, and/or a swab not supplied by Hologic will be rejected. 
  • Cadaveric patient specimens will be rejected. 
  • Specimens with clerical errors in the lab order or on the specimen tube will be rejected.
  • Unlabeled or improperly identified specimens will be rejected. 
  • Specimens transported or stored at incorrect temperatures will be rejected.
  • Specimens received past manufacturer's viability from the date of collection will be rejected. 
Testing Location
  • Nashville
  • Knoxville

This Page Last Updated: October 9, 2026 at 1:27 PM